查詢結果分析
來源資料
頁籤選單縮合
題 名 | 腎臟移植病人免疫抑制劑簡介=Introduction of Immunosuppressants for Renal Transplantation Patients |
---|---|
作 者 | 周心怡; 江俐慧; 陳惠玉; | 書刊名 | 藥學雜誌 |
卷 期 | 30:4=121 2014.12[民103.12] |
頁 次 | 頁55-59 |
分類號 | 416.273、416.273 |
關鍵詞 | 腎臟移植; 免疫抑制劑; Renal transplantation; Immunosuppression; |
語 文 | 中文(Chinese) |
中文摘要 | 慢性腎臟疾病為影響國人健康的危險因子之一,而腎臟移植為末期腎衰竭病人 的治療首選,在接受器官移植後為了預防排斥反應,病人需要接受免疫治療。現行 的免疫治療趨勢為三合一療法,藥物包括類固醇 (prednisolone)、calcineurin inhibitor (cyclosporine 或 tacrolimus)、purine antagonist (azathioprine 或 mycophenolate mofetil)。 三合一療法當中最常見的藥物組合為 prednisolone、tacrolimus 及 mycophenolate mofetil。根據藥品的特性,選擇適當的免疫抑制劑,在抗排斥與藥物毒性間找到平衡 點是最重要的用藥原則。 |
英文摘要 | Chronic kidney disease is a risk factor affecting people's health. Renal transplantation is the best treatment for patients with end-stage renal disease. After renal transplantation, patients need to receive immunosuppressive agents to prevent rejection. Immunosuppressants for renal transplantation typically consists of three types of drugs in combination: a steroid (prednisolone), calcineurin inhibitor (cyclosporine or tacrolimus), and purine antagonist (azathioprine or mycophenolate mofetil). The most common combination of oral immunosuppressants for renal transplantation currently is prednisone, tacrolimus, and mycophenolate mofetil. It is important to choose a property drug regiments to prevent the rejection and to decrease the drug adverse reactions. |
本系統中英文摘要資訊取自各篇刊載內容。